Logo Logo

Publications by Ehninger, G.

Up a level
Export as [feed] RSS 1.0 [feed] RSS 2.0
Group by: Item Type | Date
Number of items: 16.

Journal article

Ryan, D. P.; Henzel, K. S.; Pearson, B. L.; Siwek, M. E.; Papazoglou, A.; Guo, L.; Paesler, K.; Yu, M.; Müller, R.; Xie, K.; Schröder, S.; Becker, L.; Garrett, L.; Hölter, S. M.; Neff, F.; Racz, I.; Rathkolb, B.; Rozman, J.; Ehninger, G.; Klingenspor, M.; Klopstock, T.; Wolf, E.; Wurst, W.; Zimmer, A.; Fuchs, H.; Gailus-Durner, V.; Hrabe de Angelis, Martin; Sidiropoulou, K.; Weiergräber, M.; Zhou, Y.; Ehninger, D. (2018): A paternal methyl donor-rich diet altered cognitive and neural functions in offspring mice. In: Molecular Psychiatry, Vol. 23, No. 5: pp. 1345-1355

Ringden, O.; Labopi, M.; Sadeghi, B.; Mailhol, A.; Beelen, D.; Floisand, Y.; Ghavamzadeh, A.; Finke, J.; Ehninger, G.; Volin, L.; Socie, G.; Kröger, N.; Stuhler, G.; Ganser, A.; Schmid, C.; Giebel, S.; Mohty, M.; Nagler, A. (2018): What is the outcome in patients with acute leukaemia who survive severe acute graft-versus-host disease? In: Journal of Internal Medicine, Vol. 283, No. 2: pp. 166-177

Nasso, D.; Labopin, M.; Ruggeri, A.; Ciceri, F.; Lint, M. T. van; Arcese, W.; Tischer, J.; Blaise, D.; Ehninger, G.; Koc, Y.; Santarone, S.; Bruno, B.; Huang, X.-J.; Savani, B. N.; Mohty, M.; Nagler, A. (2017): Impact of Conditioning Regimen on Outcomes of T-Replete Haplo-Identical Transplantation for Patients Over 45 Years-Old with AML: A Study On Behalf Of the Acute Leukemia Working Party of the EBMT. In: Haematologica, Vol. 102: p. 132

Kohlbrenner, K.; Arnecke, L.; Fabarius, A.; Bieber, R.; Voskanyan, A.; Reiser, M.; Fenchel, K.; Schmidt, E.; Göhler, T.; Kühn, R. B.; Depenbusch, R.; Azeh, I.; Kleeberg, U. R.; Hansen, R.; Haenel, M.; Anhuf, J.; Jehner, P.; Bärlocher, G. M.; Brümmendorf, T. H.; Ehninger, G.; Hasford, J.; Heim, D.; Hossfeld, D. K.; Kolb, H.-J.; Krause, S. W.; le Coutre, P.; Nerl, C.; Neubauer, A.; Niederwieser, D.; Tesch, H.; Hochhaus, A.; Hehlmann, R.; Saussele, S. (2017): High age and high frequency of treatment switch in CML patients outside of clinical trials: interim results of the German CML VI trial. In: Oncology Research and Treatment, Vol. 40: p. 145

Silva, P.; Neumann, M.; Schroeder, M. P.; Vosberg, S.; Schlee, C.; Isaakidis, K.; Ortiz-Tanchez, J.; Fransecky, L. R.; Hartung, T.; Türkmen, S.; Graf, A.; Krebs, S.; Blum, H.; Müller-Tidow, C.; Thiede, C.; Ehninger, G.; Serve, H.; Hecht, J.; Berdel, W. E.; Greif, P. A.; Röllig, C.; Baldus, C. D. (2017): Acute myeloid leukemia in the elderly is characterized by a distinct genetic and epigenetic landscape. In: Leukemia, Vol. 31, No. 7: pp. 1640-1644

Kossak-Roth, U.; Saußele, Susanne; Aul, C.; Büchner, T.; Dohner, H.; Dugas, Martin; Ehninger, G.; Ganser, A.; Giagounidis, A.; Gökbuget, Nicola; Griesshammer, M.; Hasford, Joerg; Heuser, M.; Hiddemann, Wolfgang; Hochhaus, A.; Hoelzer, D.; Niederwieser, D. W.; Reiter, A.; Röllig, C.; Hehlmann, R. (2016): Entstehung, Entwicklung und Erfolge des Kompetenznetzes Akute und Chronische Leukämien (KNL). In: Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz, Vol. 59, No. 4: pp. 444-453

Müller-Tidow, C.; Tschanter, P.; Röllig, C.; Thiede, C.; Koschmieder, A.; Stelljes, M.; Koschmieder, S.; Dugas, M.; Gerss, J.; Butterfaß-Bahloul, T.; Wagner, R.; Eveslage, M.; Thiem, U.; Krause, S. W.; Kaiser, U.; Kunzmann, V.; Steffen, B.; Noppeney, R.; Herr, W.; Baldus, C. D.; Schmitz, N.; Götze, K.; Reichle, A.; Kaufmann, M.; Neubauer, A.; Schäfer-Eckart, K.; Hänel, M.; Peceny, R.; Frickhofen, N.; Kiehl, M.; Giagounidis, A.; Görner, M.; Repp, R.; Link, H.; Kiani, A.; Naumann, R.; Brümmendorf, Th; Serve, H.; Ehninger, G.; Berdel, W. E.; Krug, U. (2016): Azacitidine in combination with intensive induction chemotherapy in older patients with acute myeloid leukemia: The AML-AZA trial of the study alliance leukemia. In: Leukemia, Vol. 30, No. 3: pp. 555-561

Baldus, C. D.; Silva, P.; Neumann, M.; Vosberg, S.; Schlee, C.; Isaakidis, K.; Schroeder, M. P.; Tanchez, Ortiz J.; Fransecky, L. R.; Hartung, T.; Türkmen, S.; Graf, A.; Krebs, S.; Blum, H.; Thiede, C.; Ehninger, G.; Serve, H.; Berdel, W.; Greif, P. A.; Röllig, C. (2016): The distinct genetic and epigenetic landscape of elderly AML: Data of the SAL registry. In: Oncology Research and Treatment, Vol. 39: p. 5

Hehlmann, R.; Müller, M. C.; Lauseker, Michael; Hanfstein, B.; Fabarius, A.; Schreiber, A.; Proetel, U.; Pletsch, N.; Pfirrmann, Markus; Haferlach, C.; Schnittger, S.; Einsele, H.; Dengler, J.; Falge, C.; Kanz, L.; Neubauer, A.; Kneba, M.; Stegelmann, F.; Pfreundschuh, M.; Waller, C. F.; Spiekermann, Karsten; Baerlocher, Gabriela M.; Ehninger, G.; Heim, D.; Heimpel, H.; Nerl, C.; Krause, S. W.; Hossfeld, D. K.; Kolb, H. J.; Hasford, Joerg; Saußele, Susanne; Hochhaus, A. (2014): Deep Molecular Response Is Reached by the Majority of Patients Treated With Imatinib, Predicts Survival, and Is Achieved More Quickly by Optimized High-Dose Imatinib: Results From the Randomized CML-Study IV. In: Journal of Clinical Oncology, Vol. 32, No. 5: pp. 415-423

Pfirrmann, Markus; Ehninger, G.; Thiede, C.; Bornhäuser, M.; Kramer, M.; Röllig, C.; Hasford, Joerg; Schaich, M. (2012): Prediction of post-remission survival in acute myeloid leukaemia: a post-hoc analysis of the AML96 trial. In: Lancet Oncology, Vol. 13, No. 2: pp. 207-214

Büchner, T.; Schlenk, R. F.; Schaich, M.; Doehner, K.; Krahl, R.; Krauter, J.; Heil, G.; Krug, U.; Sauerland, M. C.; Heinecke, A.; Späth, Daniela; Kramer, M.; Scholl, S.; Berdel, W. E.; Hiddemann, Wolfgang; Hoelzer, D.; Hehlmann, R.; Hasford, Joerg; Hoffmann, V. S.; Doehner, H.; Ehninger, G.; Ganser, A.; Niederwieser, D. W.; Pfirrmann, Markus (2012): Acute Myeloid Leukemia (AML): Different Treatment Strategies Versus a Common Standard Arm‐Combined Prospective Analysis by the German AML Intergroup. In: Journal of Clinical Oncology, Vol. 30, No. 29: pp. 3604-3610

Stoelzel, F.; Pfirrmann, Markus; Aulitzky, W. E.; Kaufmann, M.; Bodenstein, H.; Bornhäuser, M.; Roellig, C.; Kramer, M.; Mohr, B.; Oelschlaegel, U.; Schmitz, N.; Soucek, S.; Thiede, C.; Ehninger, G.; Schaich, M. (2011): Risk stratification using a new prognostic score for patients with secondary acute myeloid leukemia: results of the prospective AML96 trial. In: Leukemia, Vol. 25, No. 3: pp. 420-428

Schaich, M.; Kestel, L.; Pfirrmann, Markus; Robel, K.; Illmer, T.; Kramer, M.; Dill, C.; Ehninger, G.; Schackert, G.; Krex, D. (2009): A MDR1 (ABCB1) gene single nucleotide polymorphism predicts outcome of temozolomide treatment in glioblastoma patients. In: Annals of Oncology, Vol. 20, No. 1: pp. 175-181

Messerer, D.; Engel, Jutta; Hasford, Joerg; Schaich, M.; Ehninger, G.; Sauerland, C.; Büchner, T.; Schumacher, A.; Krahl, R.; Niederwieser, D. W.; Krauter, J.; Ganser, A.; Creutzig, U.; Doehner, H.; Schlenk, R. F. (2008): Impact of different post-remission strategies on quality of life in patients with acute myeloid leukemia. In: Haematologica, Vol. 93, No. 6: pp. 826-833

Büchner, T.; Dohner, H.; Ehninger, G.; Ganser, A.; Niederwieser, D. W.; Hasford, Joerg (2004): Cross-trial networking in AML: a step forward rather than corner cutting. In: Leukemia Research, Vol. 28, No. 6: pp. 649-650

Hehlmann, R.; Berger, U.; Aul, C.; Büchner, Th; Dohner, H.; Ehninger, G.; Ganser, A.; Gökbuget, Nicola; Hoelzer, D.; Überla, Karl; Gassmann, W.; Ludwig, W. D.; Rieder, H.; Kneba, M.; Hochhaus, A.; Reiter, A.; Hiddemann, W.; Ottmann, O. G.; Germing, U.; Adelhard, K.; Dugas, M.; Dirschedl, P.; Messerer, D.; Böhme, A.; Harrison-Neu, E.; Griesshammer, M.; Kienast, J.; Kolb, H. J.; Ho, A. D.; Hallek, M.; Neubauer, A.; Schlegelberger, B.; Niederwieser, D.; Heil, G.; Müller, T.; Hasford, Joerg (2004): The German competence network 'Acute and chronic leukemias'. In: Leukemia, Vol. 18, No. 4: pp. 665-669

This list was generated on Mon Sep 16 06:36:19 2019 CEST.